Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine(Délégation Paris 5), Jonathan A. Ledermann(University College London), Frédèric Selle(Sorbonne Université), Val Gebski(The University of Sydney), Richard T. Penson(Massachusetts General Hospital), Amit M. Oza(Princess Margaret Cancer Centre), Jacob Korach(Tel Aviv University), Tomasz Huzarski(Pomeranian Medical University), Andrés Poveda(Fundación Instituto Valenciano de Oncología), Sandro Pignata(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Michael Friedländer(UNSW Sydney), Nicoletta Colombo(University of Milan), Philipp Harter(Kliniken Essen-Mitte), Keiichi Fujiwara(Saitama Medical University), Isabelle Ray‐Coquard(Université Claude Bernard Lyon 1), Susana Banerjee(Royal Marsden NHS Foundation Trust), Joyce F. Liu(Dana-Farber Cancer Institute), Elizabeth Lowe(AstraZeneca (United States)), Ralph Bloomfield(AstraZeneca (United Kingdom)), Patricia Pautier(Institut Gustave Roussy), Jacob Korach(Tel Aviv University), Tomasz Huzarski(Pomeranian Medical University), Tomasz Byrski(Pomeranian Medical University), Patricia Pautier(Institut Gustave Roussy), Michael Friedländer(UNSW Sydney), Philipp Harter(Kliniken Essen-Mitte), Nicoletta Colombo(University of Milan), Sandro Pignata(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Giovanni Scambia, Maria Ornella Nicoletto, Fiona Nussey, Andrew R. Clamp, Richard T. Penson(Massachusetts General Hospital), Amit M. Oza(Princess Margaret Cancer Centre), A. Poveda Velasco(Fundación Instituto Valenciano de Oncología), Manuel Rodrigues, Jean‐Pierre Lotz, Frédèric Selle(Sorbonne Université), Isabelle Ray‐Coquard(Université Claude Bernard Lyon 1), Diane Provencher, Aleix Prat Aparicio, Laura Vidal Boixader(Délégation Paris 5), Clare L. Scott, Kenji Tamura, Mayu Yunokawa, Alla Lisyanskaya, Jacques Médioni, Nicolas Pécuchet, Coraline Dubot, Thibault De La Motte Rouge, Marie‐Christine Kaminsky, B. Weber, Alain Lortholary, Christine Parkinson, Jonathan A. Ledermann(University College London), Sarah Williams, Susana Banerjee(Royal Marsden NHS Foundation Trust), Jonathan A. Cosin(University College London), James Hoffman, Richard T. Penson(Massachusetts General Hospital), Marie Plante, Allan Covens, Gabe S. Sonke, Florence Joly, Anne Floquet, Susana Banerjee(Royal Marsden NHS Foundation Trust), Holger W. Hirte, Amnon Amit(Princess Margaret Cancer Centre), Tjoung-Won Park-Simon, Koji Matsumoto, Sergei Tjulandin, Jae‐Hoon Kim(Pomeranian Medical University), Laurence Gladieff, Roberto Sabbatini, David M. O’Malley, Patrick Timmins, Daniel Kredentser, Nuria Laínez Milagro, M.P. Barretina Ginesta, Ariadna Tibau Martorell, Alfonso Gómez de Liaño, Belén Ojeda González, Linda Mileshkin, Masaki Mandai, Ingrid Boere, Petronella B. Ottevanger, Joo‐Hyun Nam, Elias Abdo Filho, Salima Hamizi, Francesco Cognetti, David Warshal, Elizabeth Dickson-Michelson(AstraZeneca (United States)), Scott Kamelle, Nathalie D. McKenzie, Gustavo C. Rodriguez, Deborah K. Armstrong, Eva Chalas, Paul Celano, Kian Behbakht, Susan A. Davidson(Royal Marsden NHS Foundation Trust), Stephen Welch, Limor Helpman, Ami Fishman(Princess Margaret Cancer Centre), Ilan Bruchim, Magdalena Sikorska, Anna Słowińska, Wojciech Rogowski, Mariusz Bidziński, Beata Śpiewankiewicz, Antonio Casado Herraez, César Mendiola Fernández, Martina Gropp‐Meier, Toshiaki Saito, Kazuhiro Takehara, Takayuki Enomoto, Hidemichi Watari, Chel Hun Choi, Byoung‐Gie Kim(Pomeranian Medical University), Jae‐Weon Kim(Pomeranian Medical University), Roberto Hegg, Ignace Vergote
The Lancet Oncology
July 25, 2017
Cited by 1,858

Abstract


Related Papers

No related papers found

Powered by citation graph analysis